(HealthDay)—Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment, remdesivir. The antiviral drug will take the brand name Veklury, the company said.
Aug 12, 2020
0
1
In The BMJ today, a panel of international experts make a weak recommendation for the use of remdesivir in patients with severe covid-19, and strongly support continued enrolment of patients into ongoing clinical trials of ...
Jul 31, 2020
0
3
Desperate to solve the deadly conundrum of COVID-19, the world is clamoring for fast answers and solutions from a research system not built for haste.
Jul 8, 2020
0
1
On Thursday, March 26 this year, working parents faced a dilemma—how were they going to work and care for their children during lockdown? The restrictions meant schools, early childcare centres, and kindergartens were closed. ...
Jul 7, 2020
0
3
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other ...
Jun 29, 2020
0
7
The pressure to send more patients home increases when hospital beds are in short supply.
May 20, 2020
0
1
Play the same piece of music to two people, and their hearts can respond very differently. That's the conclusion of a novel study presented today on EHRA Essentials 4 You, a scientific platform of the European Society of ...
May 20, 2020
1
1
A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.
May 19, 2020
0
11590
More than a dozen states let restaurants, stores or other businesses reopen Friday in the biggest one-day push yet to get their economies up and running again, acting at their own speed and with their own quirks and restrictions ...
May 2, 2020
0
2
News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest – and a clamor to know how soon it might be available.
May 1, 2020
0
14
